<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP02745822B8W1" file="EP02745822W1B8.xml" lang="en" country="EP" doc-number="1405912" kind="B8" correction-code="W1" date-publ="20121024" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY..TRBGCZEE....SK....................................</B001EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP></eptags></B000><B100><B110>1405912</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20121024</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>02745822.3</B210><B220><date>20020704</date></B220><B240><B241><date>20040108</date></B241><B242><date>20060509</date></B242></B240><B250>ja</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>2001206918</B310><B320><date>20010706</date></B320><B330><ctry>JP</ctry></B330></B300><B400><B405><date>20121024</date><bnum>201243</bnum></B405><B430><date>20040407</date><bnum>200415</bnum></B430><B450><date>20120905</date><bnum>201236</bnum></B450><B452EP><date>20120127</date></B452EP><B480><date>20121024</date><bnum>201243</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12P  21/02        20060101AFI20111102BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>GENETISCH MODIFIZIERTES ECARIN UND VERFAHREN ZU DESSEN HERSTELLUNG</B542><B541>en</B541><B542>GENETICALLY MODIFIED ECARIN AND PROCESS FOR PRODUCING THE SAME</B542><B541>fr</B541><B542>ECARINE GENETIQUEMENT MODIFIEE ET PROCEDE D'ELABORATION</B542></B540><B560><B561><text>WO-A-01/04146</text></B561><B561><text>US-A- 5 602 034</text></B561><B562><text>HOFMANN H ET AL: "BLOOD COAGULATION INDUCED BY THE VENOM OF BOTHROPS ATROX. I. IDENTIFICATION, PURIFICATION AND PROPERTIES OF A PROTHROMBIN ACTIVATOR" BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 26, no. 3, 1987, pages 772-780, XP001063236 ISSN: 0006-2960</text></B562><B562><text>NOMURA M ET AL: "In vivo induction of cytotoxic T lymphocytes specific for a single epitope introduced into an unrelated molecule" JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 193, no. 1, 14 June 1996 (1996-06-14), pages 41-49, XP004020801 ISSN: 0022-1759</text></B562><B562><text>RAKONJAC J ET AL: "Filamentous phage are released from the bacterial membrane by a two-step mechanism involving a short C-terminal fragment of pIII" JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 289, no. 5, 25 June 1999 (1999-06-25), pages 1253-1265, XP004451670 ISSN: 0022-2836</text></B562><B562><text>NISHIDA S. ET AL.: 'cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom' BIOCHEMISTRY vol. 34, no. 5, 1995, pages 1771 - 1778, XP002159171</text></B562><B562><text>MORITA T. ET AL.: 'Purification and properties of prothrombin activator from the venom of Echis carinatus' J. BIOCHEM. vol. 83, no. 2, 1978, pages 559 - 570, XP002955637</text></B562><B562><text>BRIET E. ET AL.: 'Cleavage and activation of human prothrombin by Echis carinatus venom' THROMB. RES. vol. 27, no. 5, 1982, pages 591 - 600, XP002955638</text></B562><B562><text>YAMAMOTO ET AL: JOURNAL OF CHROMATOGRAPHY, vol. 852, 1999, pages 37-41, XP004176667,</text></B562><B565EP><date>20041118</date></B565EP></B560></B500><B700><B720><B721><snm>YONEMURA, Hiroshi</snm><adr><str>1314-1, Yonnonishioki,
Kawabe,
Kyokushimura</str><city>Kikuchi-gun,
Kumamoto 869-1298</city><ctry>JP</ctry></adr></B721><B721><snm>IMAMURA, Takayuki</snm><adr><str>1314-1, Yonnonishioki,
Kawabe,
Kyokushimura</str><city>Kikuchi-gun,
Kumamoto 869-1298</city><ctry>JP</ctry></adr></B721><B721><snm>NAKATAKE, Hiroshi</snm><adr><str>1314-1, Yonnonishioki,
Kawabe,
Kyokushimura</str><city>Kikuchi-gun,
Kumamoto 869-1298</city><ctry>JP</ctry></adr></B721><B721><snm>SOEJIMA, Kenji</snm><adr><str>1314-1, Yonnonishioki,
Kawabe,
Kyokushimura</str><city>Kikuchi-gun,
Kumamoto 869-1298</city><ctry>JP</ctry></adr></B721><B721><snm>NOZAKI, Chikateru</snm><adr><str>1314-1, Yonnonishioki,
Kawabe,
Kyokushimura</str><city>Kikuchi-gun,
Kumamoto 869-1298</city><ctry>JP</ctry></adr></B721></B720><B730><B731><snm>The Chemo-Sero-Therapeutic Research Institute</snm><iid>101308697</iid><irf>H3276 EP S3</irf><adr><str>1-6-1 Okubo 
Kita-ku</str><city>Kumamoto-shi
Kumamoto 860-8568</city><ctry>JP</ctry></adr></B731></B730><B740><B741><snm>Vossius &amp; Partner</snm><iid>100751388</iid><adr><str>Siebertstrasse 4</str><city>81675 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>JP2002006770</anum></dnum><date>20020704</date></B861><B862>ja</B862></B860><B870><B871><dnum><pnum>WO2003004647</pnum></dnum><date>20030116</date><bnum>200303</bnum></B871></B870><B880><date>20040407</date><bnum>200415</bnum></B880></B800></SDOBI>
</ep-patent-document>
